baber/WOPTO huggingface dataset:
Patent DK-1352003-T3 (DK)
Inventor: COTE SIMON
IPC: C08F8/00
Filed: 2001-11-20
Granted: 2006-05-29
Abstract: The present invention fulfils desired specifications generally rarely encountered with existing solid supports such as highly amphiphile behaviour. The solid support described herein is a poly(ethylene or propylene)glycol based polymer that can be useful in solid and liquid phase synthesis, chromatography, scavenging purposes and immobilisation of proteins and reagents. More specifically, the solid support is a cross-linked polyether derived from a cross-linked polyester which is obtained by copolymerization of at least one monomer comprising (a) one-ended polymerizable vinyl or allyl ketone, ester, ether or mixtures thereof with at least one cross-linker having at least two polymerizable terminal end groups, with the exception of epoxy and oxetane end groups, or (b) divinyl benzene. The method for the preparation of the cross-linked polyether is also disclosed.
Patent DK-1225226-T3 (DK)
Inventor: MIDDELDORP J M
IPC: C07K16/00
Filed: 1993-03-10
Granted: 2008-04-14
Abstract: The present invention relates to peptides immunochemically reactive with antibodies to the Epstein-Barr virus (EBV), comprising at least part of the VCA-p18 or VCA-p40 protein, encoded within the EBV open reading frames BFRF3 and BdRF1 respectively, or a functional variant thereof. The invention further relates to nucleic acid sequences encoding these peptides, monoclonal antibodies against these peptides, cell lines capable of producing monoclonal antibodies and anti-idiotype antibodies. The invention also relates to recombinant vector molecules comprising a nucleic acid sequence according to the invention and host cells transformed or transfected with these vector molecules. The invention is further concerned with immunological reagents and methods for the detection of EBV or anti-EBV antibodies and a method for the amplification and detection of Epstein Barr viral nucleic acid.
Patent DK-1226922-T3 (DK)
Inventor: BANDERA FRANCO
IPC: B29C48/76
Filed: 2002-01-24
Granted: 2006-07-31
Abstract: Polyethyleneterephthalate extrusion equipment of material in granule form, still humid, coming from both ground recovered products and also virgin material, comprising a chassis (29), containing a co-rotating, oil-thermoregulated extruder with two screws (31, 32), which comprises a first zone (A), equipped with an opening (34) where there is an aspiration hood (35) for a first "open top" degassing, a second zone (C) where there is at least one stack (37, 38) for a further degassing, between the two zones (A, C), there being a tight zone (B), and a carrying and loading zone (E) activated by the screws (31, 32). The description also relates to an extrusion process of polyethyleneterephthalate effected in a co-rotating twin-screw extruder which comprises in a first zone (A) an "open top" degassing phase, followed by a stack (37, 38) degassing phase, between the two phases there being a tight zone which does not deteriorate the material, followed by a carrying, loading and amalgamation phase of the molten material and a final pumping phase with the extrusion of polyethyleneterephthalate. <IMAGE>
Patent DK-1419699-T3 (DK)
Inventor: BRUG JOHANNES CORNELIS
IPC: A23L23/10
Filed: 2002-11-18
Granted: 2005-04-25
Abstract: Food compositions comprising 5-80%wt of triglycerides of fatty acids, 2-80%wt of an edible salt which compositions contain less than 15%wt of water, wherein the amount of H3 (triglyceride of 3 saturated fatty acids of 16 or more carbon atoms) and H2U (triglyceride of 2 saturated fatty acids of 16 or more carbon atoms and 1 cis-unsaturated fatty acid) taken together is at least 55%wt based on the total amount of triglycerides.
Patent DK-1408953-T3 (DK)
Inventor: PLATA-SALAMAN CARLOS R
IPC: A61P25/18
Filed: 2002-02-21
Granted: 2006-08-21
Abstract: This invention is directed to a method for preventing or treating bipolar disorder comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I):wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1 and R2 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).
Patent DK-1554699-T3 (DK)
Inventor: AMIDROR ISAAC
IPC: G07D7/12
Filed: 2002-05-14
Granted: 2009-06-08
Abstract: This invention discloses new methods, security devices and apparatuses for authenticating documents and valuable articles which may be applied to any support, including transparent synthetic materials and traditional opaque materials such as paper. The invention relates to moire intensity profiles which occur in the superposition of periodic or aperiodic geometrically transformed structures. By using a specially designed basic screen and master screen, where at least the basic screen is comprised in the document, a moire intensity profile of a chosen shape becomes visible in their superposition, thereby allowing the authentication of the document. If a microlens structure is used as a master screen, the document comprising the basic screen may be printed on an opaque reflective support, thereby enabling the visualization of the moire intensity profile by reflection. Automatic document authentication is supported by an apparatus comprising a master screen, an image acquisition means such as a camera and a comparing processor whose task is to compare the acquired moire intensity profile with a reference image. Depending on the match, the document handling device connected to the comparing processor accepts or rejects the document. An important advantage of the present invention is that it can be incorporated into the standard document printing process, so that it offers high security at the same cost as standard state of the art document production.
Patent DK-1521774-T3 (DK)
Inventor: KONTSEKOVA EVA
IPC: C12N15/85
Filed: 2003-07-09
Granted: 2008-10-27
Abstract: Described are novel N- and C-terminally double truncated tau molecules, herein after designated type IIB tau molecules, characterized by the following features: 
- the molecules have at least the first 68 N-terminal amino acids and at least the last 40 C-terminal amino acids of the 4 repeat containing tau43 or the first 68 N-terminal amino acids and at least the last 20 C-terminal amino acids of the 3 repeat containing tau44 truncated, 
- the molecules are detectable in Alzheimer's diseased brain tissue, whereas the molecules are not detectable in normal healthy brain tissue, 
- the molecules have a pathological microtubule assembly promoting activity different from wild type tau in an in vitro microtubule assembly assay.
Patent DK-1596938-T3 (DK)
Inventor: HILBURG ANDREAS
IPC: A61N2/02
Filed: 2004-01-23
Granted: 2012-02-06
Abstract: An assembly and a method for carrying out magnetotherapy. Said assembly comprises an application system for applying a magnetic field to a living thing and a control unit for adjusting at least one parameter of the magnetic field. A pulse sensor records a vegetative or motoric function of the living thing and a regulating system adjusts the aforementioned parameter in accordance with the measuring signals from the pulse sensor. According to various embodiments, an aim of the invention is to create a magnetic field, in which the condition of the treated patient is reliably recorded and taken into consideration. To achieve this, the variability of the heart rate is determined from the measuring signals of the pulse sensor.
Patent DK-1590540-T3 (DK)
Inventor: HOLTSLAG JAN ANTONIE
IPC: E04F13/08
Filed: 2004-01-28
Granted: 2011-06-06
Abstract: The invention provides  (g) providing a spacer device which comprises a wedge element having a cross-section which has a narrow end and a wide end and which is connected at or near the narrow end to a clip element which has a first end connected to the narrow end of the wedge element and a second, free end, whereby the wedge element and the clip element are configured so that they define a gap between the wedge element and the clip element, (h) inserting one edge of the panel into the gap between the wedge element and the clip element, and (i) affixing the spacer device and the panel to the surface,  wherein the wedge element or the clip element or both are formed from resilient material such that the gap into which the edge of the panel is inserted has, in the absence of external forces, a width less than the thickness of the part of the panel inserted between the wedge element and the clip element and whereby the insertion of the edge of the panel forces the size of the gap to increase, thus securing the panel between the wedge element and the clip element, and the wedge element has a first surface which contacts with the surface onto which the panel is to be affixed and a second surface which contacts the panel itself.
Patent DK-1644035-T3 (DK)
Inventor: OLIVIERI ROBERTO
IPC: C12N1/06
Filed: 2004-07-15
Granted: 2011-12-19
Abstract: In place of a step of centrifugation during preparation of outer membrane vesicles (OMVs) from bacteria, the invention utilises ultrafiltration. This allows much larger amounts of OMV-containing supernatant to be processed in a much shorter time. Thus the invention provides a process for preparing bacterial OMVs, comprising a step of ultrafiltration. The ultrafiltration step is performed on an aqueous suspension of OMVs after they have been prepared from bacteria and the OMVs remain in suspension after the filtration step. The invention is particularly useful for preparing OMVs from Neisseria meningitidis.
Patent DK-1718346-T3 (DK)
Inventor: BUCHANAN FRASER JAMES
IPC: A61F2/00
Filed: 2005-02-10
Granted: 2009-05-11
Abstract: Provided is a method of producing a bioabsorbable, implantable substrate having a graded molecular weight distribution, comprising exposing at least a portion of the implantable substrate to electron beam irradiation. There is also provided a bioabsorbable, implantable substrate comprising a bioabsorbable polymer having a graded molecular weight distribution through at least a portion of its thickness.
Patent DK-1827096-T3 (DK)
Inventor: BAIER ULF
IPC: A01N25/18
Filed: 2005-11-30
Granted: 2009-06-29
Abstract: The present invention relates to a device in the form of a container made of a polymer material, which container has one or more sealed chambers, each of which comprise a liquid pheromone comprising 2-ethyl-1,6-dioxaspiro[4,4]nonane, methyl 2,4-decadiene-carboxylate and at least one alcohol selected among 2-methylbut-3-en-2-ol and 2-methylbut-3-yn-2-ol, where at least 50% of the area of the walls forming the chambers have a wall thickness in the range of from 0.1 to 1 mm and the polymer material which forms the chamber is at least in those areas an uncoated vinyl acetate/ethylene copolymer with a vinyl acetate content in the range of from 10 to 17% by weight. The invention also relates to a method of combating and for monitoring the swarming behavior of the species Pityogenes chalcographus, generally also referred to as spruce wood engraver or six-dentated bark beetle.
Patent DK-1738653-T3 (DK)
Inventor: VANNINI ANTONIO
IPC: A23G9/28
Filed: 2006-06-15
Granted: 2009-06-15
Abstract: A machine for dispensing liquid or semi-liquid food products comprises a tank (2) for containing a product (3) to be dispensed and a dispenser tap (4) formed by a guide pipe (5) in communication with the tank (2), by means of an opening (6) located on a side portion (7) of the pipe (5), and a plunger (8) axially mobile in the pipe (5), for opening or closing the opening (6). The plunger (8) is fitted with ring-shaped seals (14a, 14b) distanced from one another along a longitudinal axis (Y) of the plunger (8), to provide a hydraulic seal towards the outside of the tank (2), and auxiliary seals (17) each extending between the ring-shaped seals (14a, 14b). The auxiliary seals (17), together with the ring-shaped seals (14a, 14b), a side surface (8a) of the plunger (8) and an inner surface (16) of the guide pipe (5) located on the opposite side to the opening (6), delimit a chamber (19), sealed so as to prevent penetration by and stagnation of the product (3) in zones where it cannot be kept in the conditions suitable for its preservation.
Patent DK-2079432-T3 (DK)
Inventor: YOW GREGORY D
IPC: A61J1/20
Filed: 2007-10-16
Granted: 2011-03-14
Abstract: A vented vial adapter for retaining aerosols when accessing a vial having a pierceable seal located over an opening of the vial, the adapter comprising: 
a flexible attachment device configured to engage the vial for secure mounting of the vial adapter to the vial; 
a cannula on the attachment device, the cannula having a sharpened tip configured to pierce the seal of the vial, a vent opening adjacent the sharpened tip, a slot, and a medicament opening on the slot, the vent opening leading to a vent lumen extending through the cannula, the medicament opening leading to a medicament lumen extending through the cannula; 
a body portion having a valve in fluid communication with the medicament lumen of the cannula, the valve biased to a closed orientation and configured to allow liquid to be introduced into and removed from the vial when the valve is actuated to an open orientation; and 
an elongate filter chamber having a first opening and a second opening, the first opening in fluid communication with the vent lumen of the cannula, the filter chamber containing a first filter device and a second filter device, the first filter device disposed between the first opening and the second filter device and configured to allow passage of liquid dispersed in gas to the second filter device while blocking non-dispersed liquid, the second filter device disposed between the first filter device and the second opening and configured to absorb liquid dispersed in gas.
Patent DK-2129956-T3 (DK)
Inventor: MOESKJAER OLE
IPC: F16L55/165
Filed: 2008-02-19
Granted: 2011-06-27
Abstract: The present invention relates to an apparatus for curing a liner of a pipeline where the liner includes a resin which is curable by exposure to electromagnetic radiation of a specific wavelength or a specific wavelength range. The apparatus comprises a housing defining opposite first and second ends, an outer wall of a substantially cylindrical configuration, and an inner wall defining a substantially unobstructed through-going passage extending longitudinally through the housing between the first and second ends, and further comprises a pair of power supply wires for the supply of electrical power to the apparatus and extending from the first end of the housing, and a plurality of LED's irradiating electromagnetic radiation of the specific wavelength or the specific wavelength range. The plurality of LED's is positioned and substantially evenly distributed at the outer wall of the housing, and is connected through an electronic circuit to the pair of power supply wires. The plurality of LED's is further connected in thermal conductive relationship to heat dissipating elements freely exposed at the inner wall of the housing in the through-going passage of the housing for allowing a stream of cooling fluid to pass through the passage for dissipating heat from the heat dissipating elements and cooling the LED's.
Patent DK-2386576-T3 (DK)
Inventor: GOLETZ STEFFEN
IPC: C07K16/30
Filed: 2003-12-01
Granted: 2014-11-10
Abstract: Recognition molecules (RM), especially antibodies (A) that bind specifically to the Core-1 (C1) antigen, comprising defined amino acids sequences (1-6) given in the specification and below, are new. Recognition molecules (RM), especially antibodies (A) that bind specifically to the Core-1 (C1) antigen, comprising defined amino acids sequences (1-6): (a) AsnTyrTrpLeuGly (1); (b) AspIleTyrPro(Gly) 3TyrThrAsnTyrAsnGluLysPheLysGly (2); (c) AspIleTyrPro(Gly) 2SerTyrThrAsnTyrAsnGluLysPheLysGly (3); (d) TyrAspAlaAlaGlyProTrpPheAlaTyr (4); (e) TyrAspAlaAlaGlyProGlyPheAlaTyr (5); or (f) TyrAspAsnHisTyrPheAspTyr (6). Independent claims are also included for: (1) construct (B) consisting of (A) fused, chemically coupled or non-covalently associated with additional sequences and/or structures; (2) isolated nucleic acid (NA) containing sequences that encode at least one (A) or (B); (3) expression cassette or vector (X) comprising NA and functionally linked promoter; (4) virus or host cell that contains at least one (X); (5) organism that contains at least one host cell of (4); (6) method for preparing (A); and (7) kit containing (A) and/or (B). ACTIVITY : Cytostatic. A multibody (104; sequence of about 200 amino acids reproduced) was coupled to a chelating group then loaded with yttrium99. It was injected (dose 100 MicroCi) into the tail vein of a mouse, subcutaneously implanted with ZA-75-1 (Core-1 positive) tumor cells. A second dose was given after 3 weeks and this treatment produced a significant reduction in tumor growth (no figures given). MECHANISM OF ACTION : Neutralization of Core-1 antigen; Vaccine.
Patent DK-2332408-T3 (DK)
Inventor: BURKLY LINDA C
IPC: A61K39/395
Filed: 2006-02-17
Granted: 2013-12-02
Abstract: Methods of treating neuronal disorders, such as mechanical neuronal traumas and neurodegenerative disorders, with TWEAK or a TWEAK receptor blocking agents are presented.
Patent DK-2724716-T3 (DK)
Inventor: PARDINA PALLEJA MARIA CARMEN
IPC: A61P15/08
Filed: 2012-06-20
Granted: 2018-02-12
Abstract: The present invention relates to a new application of phosphodiesterase inhibitors for couple infertility treatment which forms an effective alternative to the invasive assisted reproductive techniques such as conjugal artificial insemination and which consists of the transvaginal administration of a phosphodiesterase inhibitor immediately before and/or after coitus. It also relates to dosage forms suitable for the intravaginal administration of phosphodiesterase inhibitors.
Patent DK-2708559-T3 (DK)
Inventor: IGAWA TOMOYUKI
IPC: G01N33/68
Filed: 2009-04-10
Granted: 2018-06-14
Abstract: The present inventors discovered that antibodies having weaker antigen-binding activity at the early endosomal pH in comparison with that at the pH of plasma are capable of binding to multiple antigen molecules with a single antibody molecule, have long half-lives in plasma, and have improved durations of time in which they can bind to antigen.
Patent DK-0393526-T3 (DK)
Inventor: GRILL BERNHARD
IPC: H03M7/40
Filed: 1990-04-12
Granted: 1996-11-18
Abstract: Sampled values of signal are transformed or filtered into a sequence reproducing the spectral compsn., quantised with varying deg. of precision and wholly or partially optimally encoded. The appearance probability of the quantised spectral coeffts. is correlated with codeword length, and the code table is reduced in size. Some codewords are arranged in a scan, and the rest divided among the remaining gaps.
Patent DK-0422938-T3 (DK)
Inventor: VEBER DANIEL F
IPC: C07K14/75
Filed: 1990-10-11
Granted: 1995-05-01
Abstract: A fibrinogen receptor antagonist of the formula <CHEM> wherein XX represents a synthetic alpha-amino acid containing a linear side chain and ZZ represents a sequence of 1, 2, 3 or 4 amino acids.
Patent DK-0389325-T3 (DK)
Inventor: COMMISSAIRE HENRI
IPC: G01S13/02
Filed: 1990-03-05
Granted: 1995-06-21
Abstract: The invention concerns the movement of land vehicles. 
<??>It involves fitting at least some vehicles (VA, VB) with a radar system and a transponder which is capable of retransmitting, with a selected frequency shift, any radar wave received in a predetermined frequency band. The radar semi-continuously transmits waves suitable for the measurement of a distance over a range of several hundred metres, and the radar receives the shifted return waves and measures the distance from these. Provision is also made for fitting certain objects or persons (P, B), not equipped with radar, with individual transponders different from those fitted on the vehicles (VA, VB). 
<IMAGE>
Patent DK-0473640-T3 (DK)
Inventor: VROEGOP WILLEM FREDERIK
IPC: A61B5/296
Filed: 1990-04-24
Granted: 1995-07-24
Abstract: An electrode for stimulating and/or detecting the muscle activity of muscles or muscle groups of a patient. The electrode comprise a carrier and electrically conductive contacts. Via a cable the contacts are connectable to a stimulation/detection device. The carrier is provided with contact elements. An elongated throw-away sheath of isolation material is detachably connectable to the carrier. When the sheath is fixed in position the contacts are on the outside of the sheath and are connected to the contact elements. <IMAGE>
Patent DK-0489790-T3 (DK)
Inventor: MUNNY KURT
IPC: A61F5/02
Filed: 1990-08-27
Granted: 1993-04-13
Abstract: PCT No. PCT/EP90/01428 Sec. 371 Date Jun. 10, 1992 Sec. 102(e) Date Jun. 10, 1992 PCT Filed Aug. 27, 1990 PCT Pub. No. WO91/03216 PCT Pub. Date Mar. 21, 1991.A hyperextension orthesis having a base plate, an abdominal rod extending downwards therefrom with a symphysis pad, branches extending to both sides with locking elements, and an upwardly extending chest rod on which the sternal pad is movably arranged. The hyperextension orthesis also includes an oblong hole provided in the chest rod, with a screw extending through the hole and connected to the sternal pad such that the chest rod is slidable with respect to the sternal pad. A sleeve is also formed in the chest rod, with the sleeve receiving a tongue extending from a lower portion of the sternal pad.
Patent DK-0509145-T3 (DK)
Inventor: STECKEL HORST
IPC: B65G21/02
Filed: 1991-12-14
Granted: 1995-05-01
Abstract: A supporting framework (1) for belt conveyors (11), especially for closed belt conveyors (11), which can be interconnected. Each section (1) which is formed from a multiplicity of sections (1) is formed from a tube (3) which may be continuous or composed of a plurality of segments connected to one another and the end regions (21, 30) of which are provided with supports (4) which are displaceable on floor foundations. Above the tube (3) a continuous catwalk (14) is provided, which is displaced in relation to the tube (3) by means of gusset plates (25, 28). In the free region of the catwalk (14), a multiplicity of vertical rods (10) are provided, which serve to receive the sets of support rollers (12) for guiding the belt conveyor (11), especially the closed belt conveyor (11). The tube (3) is provided with undertensioning (2) or overtensioning (19) to permit great lengths. <IMAGE>
Patent DK-0546231-T3 (DK)
Inventor: CANIVENC EDITH
IPC: D06M101/06
Filed: 1991-12-12
Granted: 1996-01-08
Abstract: Textiles substrates, e.g., cotton fabrics, are conditioned to impart good feel and hydrophilicity thereto, by impregnating same with an effective conditioning amount of a polydiorganosiloxane containing, per mole, at least two structural units of the formula: XRaSiO(3-a)/2 in which X is a radical:  (* CHEMICAL STRUCTURE *)  R' is a linear or branched C2-C8 alkylene radical; R" is a hydrogen atom or a C1-C6 alkyl radical; the radicals R, which may be identical or different, are each a phenyl radical, a 3,3,3-trifluoropropyl radical or an alkyl radical having from 1 to 4 carbon atoms; a is either 1 or 2; n is a number ranging from 1 to 10; and t is 0 or 1.
Patent DK-0470235-T3 (DK)
Inventor: BOBO DONALD E JR
IPC: A61M5/00
Filed: 1991-02-18
Granted: 1995-12-04
Abstract: An infusion device includes an infusion pump for delivering a liquid through an infusion conduit from a separate source of the liquid into a patient, a bubble detector for detecting the presence of an air bubble in the infusion conduit, and control circuitry responsive to the bubble detector for determining if the size of the air bubble is unacceptable. The control circuitry is configured to determine if during the time the air bubble is detected it advances a distance indicative of the unacceptable size, one embodiment counting the steps of a linear peristaltic infusion pump for that purpose.